Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 139-147

  Giri, Dipak ^a   Ittmann, Michael ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 8; MESSENGER RNA;

ARTICLE; CELL CULTURE; EPITHELIUM; EPITHELIUM CELL; GENETICS; HUMAN; MALE; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PHYSIOLOGY; PROSTATE; PROSTATE HYPERTROPHY; REFERENCE VALUE; STROMA CELL;

CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIUM; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-8; MALE; PARACRINE COMMUNICATION; PROSTATE; PROSTATIC HYPERPLASIA; REFERENCE VALUES; RNA, MESSENGER; STROMAL CELLS;

EID: 0035404541     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61681-1     Document Type: Article

References (27)

1. Glynn R, Campion E, Bouchard G, Silbert J: The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 1985, 121:78-83
2. Culig Z, Hobisch A, Cronauer M, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G, Klocker H: Regulation of prostatic growth and function by peptide growth factors. Prostate 1996, 28:392-405
3. Begun F, Story M, Hopp K, Shapiro E, Lawson R: Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic prostates. J Urol 1995, 153:839-843
4. Ropiquet F, Giri D, Lamb D, Ittmann M: FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. J Urol 1999, 162:595-599
5. Giri D, Ropiquet F, Ittmann M: Alterations in expression of FGF2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 1999, 5:1063-1071
6. Giri D, Ropiquet F, Ittmann M: FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol 1999, 180:53-60
7. Sherwood ER, Fong CJ, Lee C, Kozlowski JM: Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology 1992, 130:2955-2963
8. Ittmann M, Mansukhani A: Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 1997, 157:351-356
9. Lloyd AR, Biragyn A, Johnston JA, Taub DD, Xu L, Michiel D, Sprenger H, Oppenheim JJ, Kelvin DJ: Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes. J Biol Chem 1995, 270:28188-28192
10. Xu L, Rahimpour R, Ran L, Kong C, Biragyn A, Andrews J, Devries M, Wang JM, Kelvin DJ: Regulation of CCR2 chemokine receptor mRNA stability. J Leukoc Biol 1997, 62:653-660
11. Giri D, Ittmann M: Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 2000, 157:249-255
12. Faris M, Ensoli B, Kokot N, Nel A: Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter. AIDS 1998, 12:19-27
13. Wijelath ES, Carlsen B, Cole T, Chen J, Kothari S, Hammond WP: Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J Cell Sci 1997, 110:871-879
14. Detillieux KA, Meij JT, Kardami E, Cattini PA: Alpha1-adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts. Am J Physiol 1999, 276:H826-H833
15. Hurley MM, Tetradis S, Huang YF, Hock J, Kream BE. Raisz LG, Sabbieti MG: Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res 1999, 14:776-783
16. Ueba T, Kaspar B, Zhao X, Gage FH: Repression of human fibroblast growth factor 2 by a novel transcription factor. J Biol Chem 1999, 274:10382-10387
17. Touriol C, Morillon A, Gensac MC, Prats H, Prats AC: Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3′-untranslated region between alternative polyadenylation sites. J Biol Chem 1999, 274:21402-21408
18. Kevil C, Carter P, Hu B, DeBenedetti A: Translational enhancement of FGF-2 by elF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 1995, 11:2339-2348
19. Weiner HL, Swain JL: Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix. Proc Natl Acad Sci USA 1989, 86:2683-2687
20. Kyprianou N, Tu H, Jacobs S: Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 1996, 27:668-675
21. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. Prostate 1990, 16:71-80
22. Wuyts A, Proost P, Van Damme J: Interleukin 8 and other CXC chemokines. The Cytokine Handbook, ed 3. Edited by A Thomson. New York, Academic Press, 1998, pp 272-311
23. Anim JT, Udo C, John B: Characterization of inflammatory cells in benign prostatic hyperplasia. Acta Histochem 1998, 100:439-449
24. Nickel JC, Downey J, Young I, Boag S: Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 1999, 84: 976-981
25. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL: Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998, 51:161-167
26. Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, Kunkel SL, Burdick MD, Strieter RM: Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999, 154:1503-1512
27. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 2000, 6:2104-2119